Roger Jeffs
Director at Axsome Therapeutics, Inc. (AXSM); CEO at Liquidia Corp (LQDA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $31.9M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 14SEC | LQDALiquidia Corp | Sell Plan | 2,5051,163,170 held (−0%) | $71.39 | $179K | -61.6% |
| Jul 14SEC | LQDALiquidia Corp | Sell Plan | 32,7441,130,426 held (−3%) | $71.52 | $2.3M | -61.7% |
| Jun 11SEC | AXSMAxsome Therapeutics, Inc. | Sell Plan | 28658,653 held (−0%) | $246.18 | $70K | -31.6% |
| Jun 11SEC | AXSMAxsome Therapeutics, Inc. | Sell Plan | 28658,367 held (−0%) | $249.12 | $71K | -32.4% |
| May 28SEC | LQDALiquidia Corp | Sell Plan | 6,4281,041,667 held (−1%) | $62.18 | $400K | -56.0% |
| May 26SEC | LQDALiquidia Corp | Sell Plan | 25,0001,098,095 held (−2%) | $61.13 | $1.5M | -55.2% |
| May 26SEC | LQDALiquidia Corp | Sell Plan | 25,0001,073,095 held (−2%) | $61.52 | $1.5M | -55.5% |
| May 26SEC | LQDALiquidia Corp | Sell Plan | 25,0001,048,095 held (−2%) | $60.38 | $1.5M | -54.7% |
| May 20SEC | LQDALiquidia Corp | Sell Plan | 25,0001,173,095 held (−2%) | $56.77 | $1.4M | -51.8% |
| May 20SEC | LQDALiquidia Corp | Sell Plan | 25,0001,148,095 held (−2%) | $58.65 | $1.5M | -53.3% |
| May 20SEC | LQDALiquidia Corp | Sell Plan | 25,0001,123,095 held (−2%) | $61.30 | $1.5M | -55.3% |
| May 15SEC | LQDALiquidia Corp | Sell Plan | 25,0001,248,095 held (−2%) | $56.29 | $1.4M | -51.4% |
| May 15SEC | LQDALiquidia Corp | Sell Plan | 25,0001,223,095 held (−2%) | $58.62 | $1.5M | -53.3% |
| May 15SEC | LQDALiquidia Corp | Sell Plan | 25,0001,198,095 held (−2%) | $57.04 | $1.4M | -52.0% |
| May 12SEC | LQDALiquidia Corp | Sell Plan | 25,0001,323,095 held (−2%) | $42.14 | $1.1M | -35.0% |
| May 12SEC | LQDALiquidia Corp | Sell Plan | 25,0001,298,095 held (−2%) | $41.50 | $1.0M | -34.0% |
| May 12SEC | LQDALiquidia Corp | Sell Plan | 25,0001,273,095 held (−2%) | $54.04 | $1.4M | -49.3% |
| May 7SEC | LQDALiquidia Corp | Sell Plan | 25,0001,398,095 held (−2%) | $40.10 | $1.0M | -31.7% |
| May 7SEC | LQDALiquidia Corp | Sell Plan | 25,0001,373,095 held (−2%) | $40.78 | $1.0M | -32.9% |
| May 7SEC | LQDALiquidia Corp | Sell Plan | 25,0001,348,095 held (−2%) | $42.09 | $1.1M | -34.9% |
| Apr 21SEC | LQDALiquidia Corp | Sell Plan | 18,8391,423,095 held (−1%) | $40.60 | $765K | -32.6% |
| Apr 16SEC | LQDALiquidia Corp | Sell Plan | 3,3001,491,934 held (−0%) | $40.00 | $132K | -31.6% |
| Apr 16SEC | LQDALiquidia Corp | Sell Plan | 25,0001,466,934 held (−2%) | $40.14 | $1.0M | -31.8% |
| Apr 16SEC | LQDALiquidia Corp | Sell Plan | 25,0001,441,934 held (−2%) | $40.31 | $1.0M | -32.1% |
| Apr 14SEC | LQDALiquidia Corp | Sell Plan | 32,7441,137,599 held (−3%) | $38.37 | $1.3M | -28.6% |
| Apr 14SEC | LQDALiquidia Corp | Sell Plan | 21,4331,495,234 held (−1%) | $40.12 | $860K | -31.8% |
| Apr 13SEC | LQDALiquidia Corp | Sell Plan | 25,0001,516,667 held (−2%) | $40.12 | $1.0M | -31.8% |
| Jan 13SEC | LQDALiquidia Corp | Sell Plan | 66,6101,037,528 held (−6%) | $37.43 | $2.5M | -26.9% |
| Oct 15SEC | LQDALiquidia Corp | Sell Plan | 20,2611,032,973 held (−2%) | $23.41 | $474K | +17.0% |
- Sell
CEO Roger Jeffs sold $179K of LQDA at $71.39 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Roger Jeffs sold $2.3M of LQDA at $71.52 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Roger Jeffs sold $70K of AXSM at $246.18 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Roger Jeffs sold $71K of AXSM at $249.12 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Roger Jeffs sold $400K of LQDA at $62.18 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Roger Jeffs sold $1.5M of LQDA at $61.13 — pre-scheduled 10b5-1 plan sale.